<DOC>
	<DOCNO>NCT01904734</DOCNO>
	<brief_summary>This study aim explore whether men low testosterone level , due alter brain regulation male hormone function , previously treat testosterone , respond well men treat clomiphene citrate , agent commonly use female infertility show improve male hormone secretion case .</brief_summary>
	<brief_title>Clomid Men With Low Testosterone With Without Prior Treatment</brief_title>
	<detailed_description>Clomiphene , oral FDA-approved agent female infertility show normalize testosterone level men hypogonadotropic hypogonadism . It appear safe well tolerate . This study compare testosterone response clomiphene citrate male veteran hypothalamic hypogonadism na√Øve treatment response similar patient already receive treatment injectable transdermal testosterone . This open-label , prospective , interventional trial conduct outpatient specialty care set . We randomize 64 hypogonadal male veteran evenly divide naive previous treatment treat 8 week clomid , increase initial dose 25 mg 50 mg/day fail achieve target testosterone level ( 450 ng/dl ) first 3 week . Endpoint measurement perform Phoenix VA Health Care System ( PVAHCS ) clinical laboratory total testosterone well bioavailable testosterone sex hormone bind globulin . Total testosterone level 8 week treatment report primary endpoint . Safety measure ( CBC , liver function , PSA ) assess 8 week well . This study help serve guide design future study clomiphene hypogonadal men .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Eunuchism</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Patient eligible care Phoenix VA Health Care System Male age 3070 year testosterone level 250 ng/dl treatment able provide inform write consent evidence pituitary tumor &gt; 1mm MRI CAT scan chronic illness ( renal , cardiac , liver failure ) Prostate specific antigen ( PSA ) &gt; 4.0 ng/ml history prostate , breast , testicular cancer eye disease compromise vision ( e.g . cataract )</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>testosterone</keyword>
	<keyword>hypogonadism</keyword>
	<keyword>pituitary</keyword>
</DOC>